Of interest, Ro5-3335 and AI-10-49 are much more efficient than the thiazol-2-yl ammonium iodides on RUNX1/CBFβ binding inhibition and where further evaluated on AML cell lines. The gene discussed is CBFB; the disease is acute myeloid leukemia.